The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Bactroban Nasal Ointment 2% w/w

2.0 percent weight/weight Nasal ointment

GlaxoSmithKline (Ireland) LimitedPA1077/094/002

Main Information

Trade NameBactroban Nasal Ointment 2% w/w
Active SubstancesMupirocin calcium
Strength2.0 percent weight/weight
Dosage FormNasal ointment
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/094/002

Group Information

ATC CodeR01AX Other nasal preparations
R01AX06 mupirocin

Status

Authorised/WithdrawnAuthorised
Licence Issued17/07/1989
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back